The Trump administration has come to an agreement with AstraZeneca for the U.K.-based pharmaceutical giant to cut drug prices in the United States.
Breakdown
- AstraZeneca joins the Most Favored Nation drug price program announced by President Trump.
- The announcement follows AstraZeneca's $4.5 billion plant groundbreaking in Virginia. 12s
- The agreement comes ten days after a similar deal with Pfizer to lower Medicaid drug prices. 24s
- CMS Administrator Dr. Oz aims to align 95% of U.S. drug prices with European levels. 46s
- Further negotiations with other pharmaceutical companies and Medicare price strategies are ongoing. 1m 43s